Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02772848 · ClinicalTrials.gov registry record
Fertility in Healthy Premenopausal Women
A clinical trial, sponsored by Fujirebio Diagnostics.
- Completed
- Registry status
- 60
- Enrollment target
NCT02772848: Completed study, sponsored by Fujirebio Diagnostics.
NCT02772848 is a clinical trial that has completed, run by Fujirebio Diagnostics. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02772848 has completed, sponsored by Fujirebio Diagnostics.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The study objectives are described below: 1. Obtain serum specimens collected for one ovulatory cycle or a maximum of 33 days, but not to exceed a total of 550 ml of whole blood per subject from a minimum of 60 healthy, premenopausal subjects. Specimens will be used to determine a reference range for estradiol, FSH, LH, and progesterone assays, used as an aid in the assessment of fertility in adult, premenopausal women. 2. To store any remaining specimens for use in future assay development and to evaluate as yet undetermined assays for the development of IVDs, including additional estradiol, FSH, LH, and progesterone assays.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-07 |
What the finished NCT02772848 record still lists
NCT02772848 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02772848 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02772848 about?
NCT02772848 is a clinical study titled "Fertility in Healthy Premenopausal Women". The study objectives are described below: 1. Obtain serum specimens collected for one ovulatory cycle or a maximum of 33 days, but not to exceed a total of 550 ml of whole blood per subject from a minimum of 60 healthy, premenopausal subjects. Specimens will be used to determine a reference range f...
What is the current status of trial NCT02772848?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2016-04. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT02772848?
This trial is sponsored by Fujirebio Diagnostics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia